Actinium Pharmaceuticals, Inc. (ATNM)
Revenue
$35.09M
TTM · Period ending: · USD
ATNM Revenue
Latest reported$35.09Mperiod ending
Latest reported$35.09Mperiod ending
ATNM TTM Revenue ($0.00 → $35.09M)
TTM revenue
High-resolution chart · PNG
ATNM revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Revenue (USD) |
|---|---|
| 35,090,000 | |
| 90,000 | |
| 90,000 | |
| 90,000 | |
| 0 | |
| 0 | |
| 0 | |
| 81,000 | |
| 81,000 | |
| 81,000 | |
| 81,000 | |
| 0 | |
| 45,000 | |
| 90,000 | |
| 1,030,000 | |
| 1,053,000 | |
| 1,241,000 | |
| 1,462,000 | |
| 1,144,000 | |
| 1,121,000 | |
| 888,000 | |
| 622,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -1,444 | |
| -1,444 | |
| -1,444 | |
| -1,444 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |